Lill-brith W. Von Arx
Herlev, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Burden of long-term conditions and management of people with overweight and obesity: Data from the United Kingdom primary care cohort of the IMPACT-O study.
Journal: Diabetes, obesity & metabolism
Published: August 29, 2025
A National Cross-Sectional Survey on Real-World Experiences of Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibody Use in Adults with Migraine in Finland.
Journal: Pain and therapy
Published: December 13, 2024
Achievement of HbA1c and weight targets in adults with type 2 diabetes on once weekly injectable glucagon-like peptide-1 receptor agonist therapy in UK primary care: A retrospective, real-world study.
Journal: Diabetes, obesity & metabolism
Published: September 03, 2024
Characterizing Patients and Treatment Patterns in Moderate-to-severe Atopic Dermatitis in Finland: A Population-based Study Using National Health Data.
Journal: Acta dermato-venereologica
Published: July 26, 2024
Prevalence and treatment patterns of adult atopic dermatitis in the UK Clinical Practice Research Datalink.
Journal: Skin health and disease
Published: November 22, 2022
Therapeutic inertia related to the injectable glucagon-like peptide-1 receptor agonists dulaglutide and semaglutide in patients with type 2 diabetes in UK primary care.
Journal: Diabetes, obesity & metabolism
Published: October 27, 2022
Burden of Moderate to Severe Atopic Dermatitis in Adults from France, Italy, and the UK: Patient-Reported Outcomes and Treatment Patterns.
Journal: Dermatology and therapy
Published: May 19, 2022
Cardiovascular risk profiles: A cross-sectional study evaluating the generalizability of the glucagon-like peptide-1 receptor agonist cardiovascular outcome trials REWIND, LEADER and SUSTAIN-6 to the real-world type 2 diabetes population in the United Kingdom.
Journal: Diabetes, obesity & metabolism
Published: July 19, 2021
Be Careful What You Ask For: Effects of Benefit Descriptions on Diabetes Patients' Benefit-Risk Tradeoff Preferences.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: December 22, 2015
Treatment beliefs, health behaviors and their association with treatment outcome in type 2 diabetes.
Treatment beliefs, health behaviors and their association with treatment outcome in type 2 diabetes.
Journal: BMJ open diabetes research & care
Published: October 24, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026